Results 201 to 210 of about 80,018 (239)
Some of the next articles are maybe not open access.
Rheumatic Disease Clinics of North America, 1989
This article reviews the literature on scleroderma and pregnancy, highlighting its sparsity, confused state, and retrospective nature. It emphasizes the need for more informed prospective work. This is required for clinical management and to help understand the complex interaction between scleroderma and pregnancy.
C M, Black, W M, Stevens
openaire +2 more sources
This article reviews the literature on scleroderma and pregnancy, highlighting its sparsity, confused state, and retrospective nature. It emphasizes the need for more informed prospective work. This is required for clinical management and to help understand the complex interaction between scleroderma and pregnancy.
C M, Black, W M, Stevens
openaire +2 more sources
Current Opinion in Rheumatology, 2006
Localized scleroderma, also known as morphoea, has a variety of clinical manifestations that can include systemic involvement. Early recognition, diagnosis and treatment may improve the long-term outcome.A large multicentre study coordinated by the Pediatric Rheumatology European Society has yielded important information on the epidemiology and ...
Ronald M, Laxer, Francesco, Zulian
openaire +2 more sources
Localized scleroderma, also known as morphoea, has a variety of clinical manifestations that can include systemic involvement. Early recognition, diagnosis and treatment may improve the long-term outcome.A large multicentre study coordinated by the Pediatric Rheumatology European Society has yielded important information on the epidemiology and ...
Ronald M, Laxer, Francesco, Zulian
openaire +2 more sources
Best Practice & Research Clinical Rheumatology, 1995
In practice, the classification of scleroderma is less problematic than that of most other connective tissue diseases given the distinctive pattern of skin involvement. Classification of early and limited disease is more problematic and is difficult to separate from severe forms of Raynaud's phenomenon. Division of scleroderma into two groups depending
openaire +2 more sources
In practice, the classification of scleroderma is less problematic than that of most other connective tissue diseases given the distinctive pattern of skin involvement. Classification of early and limited disease is more problematic and is difficult to separate from severe forms of Raynaud's phenomenon. Division of scleroderma into two groups depending
openaire +2 more sources
Scleroderma (sect. Scleroderma) sect. Scleroderma
Published as part of Yang, Kun L., Lin, Jia Y., Li, Guang-Mei & Yang, Zhu L., 2025, Updates of Scleroderma (Basidiomycota, Boletales): new data from 18 selected species in China, pp.Yang, Kun L. +3 more
openaire +1 more source
Journal of the American Academy of Dermatology, 1987
After a review of some pathogenetic and pathologic aspects of scleroderma, the experimental effects of a group of agents that can inhibit the formation of connective tissue, especially the biosynthesis of collagen, are mentioned. These substances were transferred to clinical therapy of scleroderma.
openaire +2 more sources
After a review of some pathogenetic and pathologic aspects of scleroderma, the experimental effects of a group of agents that can inhibit the formation of connective tissue, especially the biosynthesis of collagen, are mentioned. These substances were transferred to clinical therapy of scleroderma.
openaire +2 more sources
Clinical and experimental dermatology, 2003
A 53-year-old woman with systemic sclerosis developed numerous cutaneous nodules, resembling keloids, on her anterior chest wall. The nodules failed to respond to therapy with topical steroid, calcipotriol, or extended photochemotherapy. This is a rare, disfiguring variant of scleroderma, unresponsive to treatment, and poorly understood.
Ling, T. C. +4 more
openaire +4 more sources
A 53-year-old woman with systemic sclerosis developed numerous cutaneous nodules, resembling keloids, on her anterior chest wall. The nodules failed to respond to therapy with topical steroid, calcipotriol, or extended photochemotherapy. This is a rare, disfiguring variant of scleroderma, unresponsive to treatment, and poorly understood.
Ling, T. C. +4 more
openaire +4 more sources
2008
The prototypic autoimmune diseases involving skin (lupus, dermatomyositis) typically result in epithelial injury and autoantibodies to characteristic cellular antigens. Disease-specific autoantibodies are also found in scleroderma, but scleroderma is different from other cutaneous autoimmune diseases because epithelial injury does not occur.
openaire +2 more sources
The prototypic autoimmune diseases involving skin (lupus, dermatomyositis) typically result in epithelial injury and autoantibodies to characteristic cellular antigens. Disease-specific autoantibodies are also found in scleroderma, but scleroderma is different from other cutaneous autoimmune diseases because epithelial injury does not occur.
openaire +2 more sources
Rheumatic Disease Clinics of North America, 1996
Evidence from multiple sources indicates that SSc does not occur randomly in the population; there are particular groups who are at greater risk. The overall incidence rate of SSc in the adult population of the United States is approximately 20 per million per year; this rate has increased from 1944 to 1973, but has been relatively stable since that ...
openaire +3 more sources
Evidence from multiple sources indicates that SSc does not occur randomly in the population; there are particular groups who are at greater risk. The overall incidence rate of SSc in the adult population of the United States is approximately 20 per million per year; this rate has increased from 1944 to 1973, but has been relatively stable since that ...
openaire +3 more sources
Dysphagia, 1990
Scleroderma (systemic sclerosis) is a connective tissue disorder characterized by thickening and fibrosis of the skin and visceral involvement that may include the heart, lungs, kidneys, and gastrointestinal tract. At least 40-50% of patients with scleroderma experience esophageal symptoms such as heartburn and dysphagia, while up to 90% of patients ...
S R, Fulp, D O, Castell
openaire +2 more sources
Scleroderma (systemic sclerosis) is a connective tissue disorder characterized by thickening and fibrosis of the skin and visceral involvement that may include the heart, lungs, kidneys, and gastrointestinal tract. At least 40-50% of patients with scleroderma experience esophageal symptoms such as heartburn and dysphagia, while up to 90% of patients ...
S R, Fulp, D O, Castell
openaire +2 more sources
Indian Journal of Pediatrics, 2023
Localised scleroderma and systemic sclerosis are rare chronic fibrosing disorders seen in children, and are collectively referred to as Juvenile Scleroderma. Histopathology of the two forms is non-distinct but they differ in terms of vasculopathy, internal organ involvement, morbidity and mortality.
openaire +2 more sources
Localised scleroderma and systemic sclerosis are rare chronic fibrosing disorders seen in children, and are collectively referred to as Juvenile Scleroderma. Histopathology of the two forms is non-distinct but they differ in terms of vasculopathy, internal organ involvement, morbidity and mortality.
openaire +2 more sources